Skip to main content
OpenTrials

Clinical trial condition

Hereditary Angioedema - Type 2

Explore clinical trials studying Hereditary Angioedema - Type 2. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Angioedema - Type 2 trial results

Recruiting

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

NCT07428499

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +17 more
Locations
  • ADARx Clinical Site Litchfield Park, Arizona, United States
  • ADARx Clinical Site Little Rock, Arkansas, United States
  • ADARx Clinical Site San Diego, California, United States
  • ADARx Clinical Site Walnut Creek, California, United States
View all 48 locations
View Trial Details
Recruiting

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

NCT06960213

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +17 more
Locations
  • ADARx Clinical Site Litchfield Park, Arizona, United States
  • ADARx Clinical Site Little Rock, Arkansas, United States
  • ADARx Clinical Site San Diego, California, United States
  • ADARx Clinical Site Walnut Creek, California, United States
View all 51 locations
View Trial Details
Enrolling by Invitation

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

NCT05396105

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +30 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Little Rock, Arkansas, United States
  • Study site San Diego, California, United States
  • Study site Santa Monica, California, United States
View all 60 locations
View Trial Details
Completed

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

NCT04618211

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +23 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Paradise Valley, Arizona, United States
  • Study site San Diego, California, United States
  • Study site Santa Monica, California, United States
View all 36 locations
View Trial Details
Completed

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

NCT06343779

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +27 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Paradise Valley, Arizona, United States
  • Study Site Little Rock, Arkansas, United States
  • Study Site San Diego, California, United States
View all 76 locations
View Trial Details
Completed

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

NCT05047185

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +23 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Paradise Valley, Arizona, United States
  • Study site St Louis, Missouri, United States
  • Study Site Vienna, Austria
View all 19 locations
View Trial Details

Related conditions